Chengdu Diao Tianfu Pharmaceutical Group

Chengdu Diao Tianfu Pharmaceutical Group is a prominent Chinese pharmaceutical company and a core subsidiary of the Chengdu Diao Pharmaceutical Group. Established in the Chengdu High-tech Industrial Development Zone, the company specializes in the research, development, and large-scale manufacturing of modern chemical drugs and traditional Chinese medicines. Its flagship product, Di'ao Xinxuekang, is a widely recognized treatment for cardiovascular diseases and was notably the first Chinese herbal medicine to receive marketing authorization in the European Union. The company's extensive portfolio also includes a variety of generic medications targeting metabolic, infectious, and gastrointestinal disorders. Diao Tianfu operates state-of-the-art, GMP-certified production facilities that support its mission to provide high-quality healthcare solutions. As a key player in the Sichuan pharmaceutical cluster, it maintains a strong domestic market presence while pursuing international quality standards.